A novel complex of proteins binds the HIV-1 promoter upon virus interaction with CD4

Journal of Biomedical Science

Volumn 5, Issue 4, 1998, Pages 281-289

  Coudronnière, Nolwenn ^a   Devaux, Christian ^a  

^a Centre National de la Recherche Scientifique   (France)

Author keywords

CD4; HIV transcription; Signaling

Indexed keywords

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN RNA BINDING; T LYMPHOCYTE SUBPOPULATION; VIRUS CELL INTERACTION; VIRUS GENE;

EID: 0031856406     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/bf02255860     Document Type: Article

References (47)

1. Alizon M, Wain-Hobson S, Montagnier L, Sonigo P. Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients. Cell 46:63-74;1986.
2. Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868-871;1983.
3. Benkirane M, Corbeau P, Housset V, Devaux C. An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provirus transcription in HIV-infected T cells. EMBO J 12:4909-4921;1993.
4. Benkirane M, Hirn M, Carrière D, Devaux C. Functional epitope analysis of the human CD4 molecule: Antibodies that inhibit human immunodeficiency virus type 1 gene expression bind to the immunoglobulin CDR3-like region of CD4. J Virol 69:6898-6903;1995.
5. Benkirane M, Jeang KT, Devaux C. The cytoplasmic domain of CD4 plays a critical role during the early stages of HIV infection in T-cells. EMBO J 13:5559-5569;1994.
6. Benkirane M, Schmid-Antomarchi H, Littman DR, Hirn M, Rossi B, Devaux C. The cytoplasmic tail of CD4 is required for inhibition of human immunodeficiency virus type 1 replication by antibodies that bind to the immunoglobulin CDR3-like region in domain 1 of CD4. J Virol 69:6904-6910;1995.
7. Berkhout B, Gatignol A, Rabson A, Jeang KT. TAR-independent activation of the HIV-1 LTR: Evidence that Tat requires specific regions of the promoter. Cell 62:757-767;1990.
8. Berkhout B, Jeang KT. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of human immunodeficiency virus type 1 long terminal repeat. J Virol 66:139-149;1992.
9. Berkhout B, Silverman RH, Jeang KT. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 59: 273-282;1989.
10. Briant L, Coudronnière N, Robert-Hebmann V, Benkirane M, Devaux C. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection. J Immunol 156:3994-4004;1996.
11. Chirmule N, Kalyanaraman VS, Pahwa S. Signals transduced through the CD4 molecule on T lymphocytes activate NF-κB. Biochem Biophys Res Commun 203:498-505;1994.
12. Chang HK, Gallo RC, Ensoli B. Regulation of cellular gene expression and function by the human immunodeficiency virus type 1 Tat protein. J Biomed Sci 2:189-202;1995.
13. Corbeau P, Benkirane M, Weil R, David C, Emiliani S, Olive D, Mawas C, Serre A, Devaux C. Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not viral entry. J Immunol 150: 290-301;1993.
14. Costello R, Lipcey C, Algarté M, Cerdan C, Baeuerle PA, Olive D, Imbert J. Activation of primary human T lymphocytes through CD2 plus CD28 adhesion molecules induces long-term nuclear expression of NF-κB. Cell Growth Differ 4:329-339;1993.
15. Coudronnière N, Corbeil J, Robert-Hebmann V, Mesnard JM, Devaux C. The lck protein tyrosine kinase is not involved in antibody-mediated CD4 (CDR3-loop) signal transduction that inhibits HFV-1 transcription. Eur J Immunol 28:1445-1457;1998.
16. Coudronnière N, David C, Hirn M, Devaux C. In vitro selection of human immunodeficiency virus type 1 resistant to an anti-CD4 antibody that inhibits virus transcription. J AIDS Hum Retrovirol 17:17-26;1998.
17. Dimitrov DS. How do viruses enter cells? The HIV coreceptors teach us a lesson of complexity. Cell 91:721-730;1997.
18. Ellrodt A, Barré-Sinoussi F, Le Bras P, Nugeyre MT, Brun-Vézinet F, Rouzioux C, Segond P, Caquet R, Montagnier L, Chermann JC. Isolation of human T-lymphotropic retrovirus (LAV) from Zairian married couple, one with AIDS, one with prodromes. Lancet i:1383-1385;1984.
19. Emiliani S, Coudronnière N, Delsert C, Devaux C. Structural and functional properties of HIV-1GER TAR sequences. J Biomed Sci 3: 31-40;1996.
20. Emiliani S, Delsert C, David C, Devaux C. The long terminal repeat of the human immunodeficiency virus type 1 GER isolate shows a duplication of the TAR region. AIDS Res Hum Retroviruses 10:1751-1752;1994.
21. Herrmann CH, Rice AP. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxy-terminal domain of the large subunit of RNA polymerase II: Candidate for a Tat cofactor. J Virol 69:1612-1620;1995.
22. Hoover T, Mikovits J, Court D, Liu YL, Kung HF, Raziuddin. A nuclear matrix-specific factor that binds a specific segment of the negative regulatory element (NRE) of HIV-1 LTR and inhibits NF-κB activity. Nucleic Acids Res 24: 1895-1900;1996.
23. Jabado N, Le Deist F, Fischer A, Hivroz C. Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-κB and AP-I, three nuclear factors regulating interleukin-2 gene enhancer activity. Eur J Immunol 24:2646-2652;1994.
24. Jabado N, Pallier A, Jauliac S, Fischer A, Hivroz C. gp160 of HIV or anti-CD4 monoclonal antibody ligation of CD4 induces inhibition of JNK and ERK-2 activities in human peripheral CD4+ T lymphocytes. Eur J Immunol 27:394-404;1997.
25. James W, Weiss RA, Simon JHM. The receptor for HIV: Dissection of CD4 and studies on putative accessory factors. In: Littman DR, ed. The CD4 Molecule: Roles in T Lymphocytes and in HIV Disease. Curr Top Microbiol Immunol 205. New York, Springer, 137-158; 1996.
26. Jeang KT, Berkhout B, Dropulic B. Effects of integration and replication on transcription of the HIV-1 long terminal repeat. J Biol Chem 268:24940-24949;1993.
27. Jeang KT, Chun R, Lin NH, Gatignol A, Glabe CG, Fan H. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J Virol 67:6224-6233;1993.
28. Lemasson I, Briant L, Hague B, Coudronnière N, Heron L, David C, Rebouissou C, Kindt T, Devaux C. An antibody that binds domain 1 of CD4 inhibits replication of HIV-1, but not HTLV-I, in a CD4-positive/p561ck-negative HTLV-I-transformed cell line. J Immunol 156: 859-865;1996.
29. Laspia MF, Rice AP, Mathews MB. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell 59:283-292;1989.
30. Levy JA, Hoffman AD, Kramer SM, Landis JA, Shimabukuro JM, Oshiro JM. Isolation of lymphocytopathic retrovirus from San Francisco patients with AIDS. Science 225:840-842; 1984.
31. Madore SJ, Cullen BR. Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function. J Virol 67: 3703-3711;1993.
32. Myers G, Korber B, Foley B, Jeang KT, Mellors JW, Wain-Hobson S. A compilation and analysis of nucleic acid and amino acid sequences. In: Human Retroviruses and AIDS. Group T-10, Los Alamos, Los Alamos National Laboratory, 1996.
33. Neuveul C, Jeang KT. Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture. J Virol 70:5572-5581:1996.
34. Parada CA, Roeder RG. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature 384:375-378;1996.
35. Péléraux A, Peyron JF, Devaux C. Inhibition of HIV-1 replication by a monoclonal antibody directed toward the complementarity determining region 3-like domain of CD4 in CD45 expressing and CD45 deficient cells. Virology 242:233-237;1998.
36. Ravichandran KS, Collins TL, Burakoff SJ. CD4 and signal transduction. In: Littman DR, ed. The CD4 Molecule: Roles in T Lymphocytes and in HIV Disease. Curr Top Microbiol Immunol 205. New York, Springer, 47-62; 1996.
37. Rey F, Donker G, Hirsch I, Chermann JC. Productive infection of CD4+ cells by selected HIV strains is not inhibited by anti-CD4 monoclonal antibodies. Virology 181:165-171; 1991.
38. Rey MA, Spire B, Dormont D, Barré-Sinoussi F, Montagnier L, Chermann JC. Characterization of the RNA-dependent DNA polymerase of a new human T-lymphotropic retrovirus (LAV). Biochem Biophys Res Commun 121: 126;1984.
39. Schmid-Antomarchi H, Benkirane M, Breittmayer V, Husson H, Ticchioni M, Devaux C, Rossi B. HIV induces activation of phosphatidylinositol 4-kinase and mitogen-activated protein kinase by interacting with T cell CD4 surface molecules. Eur J Immunol 26:717-720; 1996.
40. Sodroski J, Patarca C, Rosen C, Wong-Staal F, Haseltine WA. Location of the transactivating region on the genome of human T-cell lymphotropic virus type III. Science 229:74-79:1985.
41. Stevenson M, Stanwick TL, Dempsey MP, Lamonica CA. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J 9:1551-1560;1990.
42. Vartanian JP, Meyerhans A. Asjö B, WainHobson S. Selected recombinant G > A hypermutation of human immunodeficiency type 1 genome. J Virol 65:1779-1788;1991.
43. Vartanian JP, Meyerhans A, Sala M, WainHobson S. G>A hypermutation of the HIV-1 genome: Evidence for dCTP pool imbalance during reverse transcription. Proc Natl Acad Sci USA 91:3092-3096;1994.
44. Xiao H, Lis JT, Jeang KT. Promoter activity of Tat at steps subsequent to TATA-binding protein recruitment. Mol Cell Biol 17:6898-6905; 1997.
45. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen ISY. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure. Cell 61: 213-222;1990.
46. Zhang X, Gaubin M, Briant L, Srikantan V, Murali R, Saragovi U, Weiner D, Devaux C, Autiero M, Piatier-Tonneau D, Greene MI. Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes. Nat Biotechnol 15:150-154;1997.
47. Zhou Q, Sharp PA. Novel mechanism and factor for regulation of HIV-1 Tat. EMBO J 16: 321-328;1995.